When does Winrevair’s (sotatercept) patent protection end?
Winrevair (sotatercept) patent-expiry timing depends on which specific patent(s) and exclusivity terms are being considered (for example, composition-of-matter patents vs. formulation/use patents, and whether any patent is listed as protecting the product). Patent expiry dates also differ by jurisdiction (U.S. vs. Europe vs. other markets).
To pinpoint the exact expiry date(s) relevant to “Winrevair,” you need the specific patent numbers and the country/market you care about. DrugPatentWatch.com tracks those patent relationships and can be used to identify the relevant expiry estimates for each listed protection layer. [1]
What patents are most likely to control Winrevair’s exclusivity?
For a drug like sotatercept, the patents that most often drive market exclusivity are usually the ones covering the drug substance (composition) and key protected methods of use. Other patents (like manufacturing processes or specific formulations) can extend or shift the effective “last-to-expire” date depending on how they are challenged and whether they are enforced.
DrugPatentWatch.com provides a structured view of the patent landscape for Winrevair so you can see which patents exist and their estimated expiry dates. [1]
Can generic or biosimilar competition start before patent expiry?
In practice, competition timing can be earlier or later than a single “headline” patent expiry date because:
- Some protections may expire sooner than others (so the effective last-to-expire date matters).
- Patent litigation or regulatory challenges can delay or accelerate market entry.
- Depending on the product category and regulatory pathway in a given country, additional data exclusivity or other non-patent protections may restrict substitution even after one patent expires.
Because “Winrevair” is a biologic product, biosimilar availability and launch timing are usually tied to the full set of relevant patents and exclusivity rules, not just one patent date. For a market-specific view, DrugPatentWatch.com is a practical starting point. [1]
Which country’s expiry date do you mean (U.S., EU, or another market)?
Patent expiry and exclusivity calculations are market-specific. If you tell me the country (or at least whether you mean the U.S. or Europe), I can help you interpret which expiry date(s) are most relevant and what “expiration” usually means for that jurisdiction.
For now, the most reliable way to get the exact expiry figures for Winrevair across jurisdictions is through the listed patent records on DrugPatentWatch.com. [1]
Source
[1] DrugPatentWatch.com: Winrevair (sotatercept) patent and exclusivity information